SmileDirectClub shares plunge after bankruptcy filing, with Syndax and AMC shares climbing and other active stocksMarket Watch • 10/02/23
Syndax to Announce Topline Results from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia and Host an Investor Call on October 2, 2023PRNewsWire • 09/29/23
Syndax Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Business UpdatePRNewsWire • 08/03/23
Syndax to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast on August 3, 2023PRNewsWire • 07/25/23
Syndax and Incyte Announce Positive Topline Results from the Pivotal AGAVE-201 Trial of Axatilimab in Chronic Graft-Versus-Host DiseasePRNewsWire • 07/24/23
Syndax Pharmaceuticals: Precision Oncology Leveraging Strong Financials And R&DSeeking Alpha • 06/08/23
Syndax Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Business UpdatePRNewsWire • 05/08/23
Syndax to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 8, 2023PRNewsWire • 05/01/23
Syndax Pharmaceuticals Announces Appointment of Neil Gallagher, M.D., Ph.D. as President, Head of Research and DevelopmentPRNewsWire • 03/30/23
Syndax Pharmaceuticals Announces Two Publications in Nature of Data from the Phase 1 Portion of AUGMENT-101 in Acute Leukemia PatientsPRNewsWire • 03/15/23
Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Business UpdatePRNewsWire • 02/28/23
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syndax Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of DirectorsPRNewsWire • 02/27/23
Syndax to Announce Fourth Quarter and Year-end 2022 Financial Results and Host Conference Call and Webcast on February 28, 2023PRNewsWire • 02/21/23
Syndax (SNDX) Is a Great Choice for 'Trend' Investors, Here's WhyZacks Investment Research • 01/20/23
Are You Looking for a Top Momentum Pick? Why Syndax Pharmaceuticals (SNDX) is a Great ChoiceZacks Investment Research • 01/18/23
Wall Street Analysts Believe Syndax (SNDX) Could Rally 44%: Here's is How to TradeZacks Investment Research • 01/04/23